PMM2-CDG caused by uniparental disomy: Case report and literature review

JIMD Reports
Laurien VaesE Morava

Abstract

Phosphomannomutase 2 deficiency (PMM2-CDG) affects glycosylation pathways such as the N-glycosylation pathway, resulting in loss of function of multiple proteins. This disorder causes multisystem involvement with a high variability among patients. PMM2-CDG is an autosomal recessive disorder, which can be caused by inheriting two pathogenic variants, de novo mutations or uniparental disomy. Our patient presented with multisystem symptoms at an early age including developmental delay, ataxia, and seizures. No diagnosis was obtained till the age of 31 years, when genetic testing was reinitiated. The patient was diagnosed with a complete maternal mixed hetero/isodisomy of chromosome 16, with a homozygous pathogenic PMM2 variant (p.Phe119Leu) causing PMM2-CDG.A literature review revealed eight cases of uniparental disomy as an underlying cause of CDG, four of which are PMM2-CDG. Since the incidence of homozygosity for PMM2 variants is rare, we suggest further investigations for every homozygous PMM2-CDG patient where the segregation does not fit. These investigations include testing for UPD or a deletion in one of the two alleles, as this will have an impact on recurrence risk in genetic counseling.

References

Jan 1, 1980·American Journal of Medical Genetics·E Engel
Nov 1, 1996·Journal of Medical Genetics·A C NichollsF M Pope
Jun 5, 2001·Genetics in Medicine : Official Journal of the American College of Medical Genetics·L G ShafferS B Cassidy
Nov 1, 2002·Pediatric Research·Stephanie GrunewaldJaak Jaeken
Aug 2, 2005·European Journal of Medical Genetics·E SchollenG Matthijs
Feb 20, 2007·Molecular Genetics and Metabolism·Els SchollenGert Matthijs
Aug 31, 2010·American Journal of Medical Genetics. Part C, Seminars in Medical Genetics·Kazuki YamazawaAnne C Ferguson-Smith
May 5, 2011·Journal of Inherited Metabolic Disease·Samira AchouitarEva Morava
Nov 26, 2011·Molecular Genetics and Metabolism·Belén PérezLourdes R Desviat
Apr 9, 2013·American Journal of Human Genetics·Bobby G NgHudson H Freeze
Feb 11, 2014·American Journal of Human Genetics·Hudson H FreezeBobby G Ng
Mar 4, 2017·Human Mutation·Miguel Alsina CasanovaJulio Moreno Hernando
Oct 29, 2017·European Journal of Medical Genetics·Romain PéanneJaak Jaeken
Apr 3, 2018·Trends in Genetics : TIG·Bobby G Ng, Hudson H Freeze
May 16, 2018·Neuromuscular Disorders : NMD·Brianna N BrunKatherine D Mathews
Feb 12, 2019·Annals of Translational Medicine·Irene J ChangChristina T Lam
Apr 10, 2019·Clinical Epigenetics·Katharina V SchulzePaweł Stankiewicz

❮ Previous
Next ❯

Methods Mentioned

BETA
glycosylation
exome sequencing

Related Concepts

Related Feeds

Ataxias (MDS)

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Ataxia

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.